From the Office of Inclusion (D.A., C.F., E.H.), Diversity, and Equity; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Ophthalmology (J.B.B.), David Geffen School of Medicine, Stein Eye Institute, University of California, Los Angeles, California, USA.
Am J Ophthalmol. 2022 Jul;239:154-158. doi: 10.1016/j.ajo.2022.03.011. Epub 2022 Mar 18.
Enhancing diversity on boards has been linked to greater profitability and innovation. Unfortunately, there remains an underrepresentation of women in executive management and leadership positions in the ophthalmic corporate world. The purpose of these analyses was to examine the gender composition of directors for boards associated with the discipline of ophthalmology.
Cross-sectional research design.
Using contemporary data, we examined a specific cohort, the American Academy of Ophthalmology (AAO) Foundation Ophthalmic Business Council corporate members as reported in the annual 2019 meeting program (N = 23). The board composition was analyzed using an online search of publicly available information in January and February 2020. The specific outcome measures included the number and percentage of women board members and their roles.
There were a total of 23 Ophthalmic Business Council members with publicly available data; 37 of 195 total directorship seats (19%) were held by women, and 9 of 23 companies (39%) listed women as previous or current chairs of committees or outside corporations. Four of the 23 (17%) members of the Ophthalmic Business Council corporations had no women directors.
The boards of directors of the AAO Foundation Ophthalmic Business Council corporate members remain predominately male. Despite the increasing number of women entering the specialty, women remain underrepresented in the corporate world of ophthalmology. Gender parity on boards is essential for the economic well-being of ophthalmic corporations as well as the relationship of the Ophthalmic Business Council with AAO members, health care systems, insurance carriers, government officials, and the public.
在董事会中增加多样性与更高的盈利能力和创新能力相关。不幸的是,在眼科企业界的高管管理和领导职位中,女性仍然代表性不足。这些分析的目的是检查与眼科相关学科的董事会中董事的性别构成。
横断面研究设计。
使用当代数据,我们检查了一个特定的队列,即美国眼科学会(AAO)基金会眼科商业理事会的公司成员,如 2019 年年会计划(N=23)中所报告的。在 2020 年 1 月和 2 月,我们通过在线搜索公开可用信息,对董事会组成进行了分析。具体的结果测量包括女性董事会成员的数量和百分比,以及她们的角色。
共有 23 名眼科商业理事会成员提供了公开数据;195 个总董事职位中有 37 个(19%)由女性担任,23 家公司中有 9 家(39%)列出了女性担任委员会或外部公司的前任或现任主席。眼科商业理事会公司的 23 名成员中有 4 名(17%)没有女性董事。
AAO 基金会眼科商业理事会公司成员的董事会仍然主要是男性。尽管越来越多的女性进入该专业,但女性在眼科企业界的代表性仍然不足。董事会的性别平等对于眼科公司的经济福祉以及眼科商业理事会与 AAO 成员、医疗保健系统、保险公司、政府官员和公众的关系至关重要。